GMO U.S. Quality Equity IV
40 Rowes Wharf Boston MA 02110
Map
Phone: 800-225-5291
| Category: | Large Blend | | Fund Family: | GMO | | Net Assets: | 314.21M | | Year-to-Date Return: | -22.98% | | Yield: | 2.02% | | Morningstar Rating: |  | | Fund Inception Date: | 06-Feb-04 |
|
Sam Wilderman
Lead Manager since
30-Apr-05 | | | Wilderman is the director of U.S. equity management since 2005 and is responsible for all U.S. quantitative equities portfolio management at Grantham, Mayo, Van Otterloo & Co. LLC (GMO). Prior to this, he was a member of GMOs Emerging Markets Equity Group for nine years, focusing on research and portfolio management. Wilderman joined GMO in 1996. Wilderman holds the Chartered Financial Analyst designation. |
| Min Initial Investment: | $125,000,000 | | Min Initial Investment, IRA: | $0 | | Min Initial Investment, AIP: | $0 | | Min Subsequent Investment: | $0 | | Min Subsequent Investment, IRA: | $0 | | Min Subsequent Investment, AIP: | $0 |
|
| |
| The investment seeks a high total return. The fund will typically invest at least 80% of assets in equity investments economically tied to the U.S. It may use a variety of exchange-traded and over-the-counter derivative instruments, including options, futures, and swap contracts. The fund is nondiversified. |
| Last Dividend
(2-Oct-08):
| 0.09 | | Last Cap Gain
(10-Jul-08):
| 0.12 | | Annual Holdings Turnover
| 46.00% | | Average for Category:
| 71.85% |
|
| Expense | GQEFX | Category
Avg | | Total Expense Ratio: | 0.44%
| 1.11% | | Max 12b1 Fee: | 0.00%
| N/A | | Max Front End Sales Load: | 0.00%
| 5.14% | | Max Deferred Sales Load: | 0.00%
| 2.63% | | 3 Yr Expense Projection*: |
$146 | $572 | | 5 Yr Expense Projection*: |
$256 | $876 | | 10 Yr Expense Projection*: |
$577 | $2,504 |
|
|
0.31% Nasdaq 0.00%
Profile
